Featured Experience
PTAB Trials: IPRs, PGRs, DERs
Sterne Kessler’s PTAB Trials team is deeply experienced in all proceedings at the PTAB, including inter partes reviews (IPRs), post-grant reviews (PGRs), and derivation proceedings (DERs). We emerged as a leader at the inception of the PTAB, and continue to be a dominant force in the industry today. We are among the top 10 most active firms at the PTAB, representing petitioners and patent owners across all technologies, including biotechnology, electronics, consumer products, automotive, and many others.
Artificial Intelligence
In the rapidly evolving world of artificial intelligence (AI), safeguarding your intellectual property (IP) is critical. As a market and thought leader in the technology sector, Sterne Kessler helps clients develop comprehensive IP solutions that protect innovation, foster growth, and maximize value. Whether you are an emerging startup company or a well-established technology pioneer, we are committed to helping you harness the full potential of AI technology.
Pharmaceutical Patent Litigation
At Sterne Kessler, we know what it takes to win across any venue in pharmaceutical IP litigation. Our award-winning team has a deep bench of experienced litigators representing biosimilars as well as generic and specialty brand pharmaceutical companies in high-profile patent litigation, including blockbuster Abbreviated New Drug Application (ANDA) and Biologics Price Competition and Innovation Act (BPCIA) matters.
ITC Litigation
With one of the nation’s top ITC practices, Sterne Kessler offers unrivaled experience, comprehensive litigation strategy, and the legal and technical know-how to achieve the best possible results. In the last five years, Sterne Kessler has handled more cases at the ITC than 90% of firms appearing before the Commission.
Design Patents
For nearly four decades, Sterne Kessler has been at the forefront of design patents, consistently delivering successful outcomes for clients in securing and defending their design rights. We develop effective, comprehensive IP programs to protect some of the most iconic product designs in the world and to eliminate knock-offs in the marketplace.
Featured News
More News & Insights
Sterne Kessler Director Gaby L. Longsworth Named to WIPR’s List of Influential Women in IP 2026
Washington, D.C. (July 8, 2026) – Sterne, Kessler, Goldstein & Fox Director Gaby L. Longsworth, Ph.D. was named to World Intellectual Property Review’s (WIPR) Influential Women in IP…
IPR or EPR? Five Scenarios and a Decision Tree for Post-Grant Patent Challengers in the Life Sciences
The total number of petitions for inter partes review (IPR) at the Patent Trial and Appeal Board (PTAB) has plummeted over the last year, corresponding closely with the…
Are You Already Creating the Evidence That Could Help Protect Your Brand?
The expansion of online retail has changed not only how brands reach consumers, but also how infringers imitate and distribute branded products. Not surprisingly, rights holders have responded…
Designing Digital Experiences: An Introduction to GUIs
Summer Associates Carson Story and Tash Medde-Witage contributed to this article. Consider the ease of making a phone call on a smartphone, ordering from your favorite pizza place’s…
Thomson Reuters Changemakers: Guesswork Replaced. Patent Secured.
Sterne Kessler Director Daniel Block was featured in Thomson Reuters’ Changemakers series, highlighting the recent partnership between Sterne Kessler and Thomson Reuters to develop the Patent Claim Eligibility…
Director Squires Reshapes Director Review in Light & Wonder
On June 22, 2026, USPTO Director John Squires issued a precedential decision in Light & Wonder, Inc. v. Evolution Malta Ltd., IPR2025-01072 et seq., Paper 30. The decision…
Your innovations are worth the best protection
Expertise
Sterne Kessler is a full-service IP firm that delivers innovative solutions tailored to your business and industry.